Silver Book reference

Fracture Risk Reduction with Alendronate in Women with Osteoporosis: The fracture intervention trial

1 Matching Fact

Search matching Facts:
No results to display
    • Alendronate, a bisphosphonate, has been shown to reduce risk of hip fracture by around 53%, clinical vertebral fracture by 45%, and wrist fracture by 30%.